Ustekinumab as induction and maintenance therapy for Crohn's disease

UNITI-IM-UNITI Study Group

Research output: Contribution to journalArticlepeer-review

724 Scopus citations

Fingerprint

Dive into the research topics of 'Ustekinumab as induction and maintenance therapy for Crohn's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences